trial · primary record
Xanomeline/Trospium Chloride Capsule
Alzheimer's Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 426 |
| Primary completion | 2028-11-13 |
| Primary endpoint | Change from baseline on the Cohen-Mansfield Agitation Inventory-International Psychogeriatric Association (CMAI-IPA) total score at Week 14 |
| Registry ID | NCT07011745 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:47.228Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07011745
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.